Ignite Creation Date:
2025-12-24 @ 10:29 PM
Ignite Modification Date:
2026-02-21 @ 11:15 AM
Study NCT ID:
NCT03663335
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2018-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients
Sponsor:
Novartis Pharmaceuticals
Organization: